Cork University Hospital is a large university teaching hospital in Wilton, Cork in Ireland. Its academic partner is University College Cork. It is the only Level 1 Trauma Centre in Ireland. It is a public hospital managed by the South/Southwest Hospital Group, a part of the Health Service Executive.

There are 800 beds in Cork University Hospital.

During the past decade, Cork University Hospital conducted 93 clinical trials. In the 10-year time frame, 93 clinical trials started and 34 clinical trials were completed, i.e. on average, 36.6% percent of trials that started reached the finish line to date. In the past 5 years, 36 clinical trials started and 27 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cork University Hospital" #1 sponsor was "Cancer Trials Ireland" with 31 trials, followed by "University College Cork" with 15 trials sponsored, "Cork University Hospital" with 14 trials sponsored, "Hoffmann-La Roche" with 9 trials sponsored and "Vertex Pharmaceuticals Incorporated" with 9 trials sponsored. Other sponsors include 84 different institutions and companies that sponsored additional 70 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cork University Hospital" #1 collaborator was "Cancer Trials Ireland" with 8 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 5 trials as a collaborator, "Breast International Group" with 4 trials as a collaborator, "Cork University Hospital" with 4 trials as a collaborator and "Health Research Board, Ireland" with 4 trials as a collaborator. Other collaborators include 153 different institutions and companies that were collaborators in the rest 128 trials.

According to Clinical.Site data, the most researched conditions in "Cork University Hospital" are "Breast Cancer" (19 trials), "Cystic Fibrosis" (13 trials), "Prostate Cancer" (6 trials), "Colorectal Cancer" (4 trials) and "Multiple Myeloma" (4 trials). Many other conditions were trialed in "Cork University Hospital" in a lesser frequency.

Most popular intervention types in "Cork University Hospital" are "Drug" (101 trials), "Other" (35 trials), "Biological" (16 trials), "Procedure" (12 trials) and "Radiation" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "IVA" (8 trials), "Carboplatin" (6 trials), "Cyclophosphamide" (5 trials) and "Docetaxel" (5 trials). Other intervention names were less common.

The vast majority of trials in "Cork University Hospital" are 123 trials for "All" genders, 30 trials for "Female" genders and 14 trials for "Male" genders.

Currently, there are NaN active trials in "Cork University Hospital". 1 are not yet recruiting, 23 are recruiting, 36 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 77 completed trials in Cork University Hospital, undefined suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in Cork University Hospital, 7 "Phase 1" clinical trials were conducted, 34 "Phase 2" clinical trials and 78 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 22 trials that are defined as “Not Applicable".